Title |
Role of TNFα in pulmonary pathophysiology
|
---|---|
Published in |
Respiratory Research, October 2006
|
DOI | 10.1186/1465-9921-7-125 |
Pubmed ID | |
Authors |
Srirupa Mukhopadhyay, John R Hoidal, Tapan K Mukherjee |
Abstract |
Tumor necrosis factor alpha (TNFalpha) is the most widely studied pleiotropic cytokine of the TNF superfamily. In pathophysiological conditions, generation of TNFalpha at high levels leads to the development of inflammatory responses that are hallmarks of many diseases. Of the various pulmonary diseases, TNFalpha is implicated in asthma, chronic bronchitis (CB), chronic obstructive pulmonary disease (COPD), acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). In addition to its underlying role in the inflammatory events, there is increasing evidence for involvement of TNFalpha in the cytotoxicity. Thus, pharmacological agents that can either suppress the production of TNFalpha or block its biological actions may have potential therapeutic value against a wide variety of diseases. Despite some immunological side effects, anti-TNFalpha therapeutic strategies represent an important breakthrough in the treatment of inflammatory diseases and may have a role in pulmonary diseases characterized by inflammation and cell death. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 42% |
Belgium | 1 | 8% |
Unknown | 6 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 10 | 83% |
Practitioners (doctors, other healthcare professionals) | 1 | 8% |
Scientists | 1 | 8% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 1% |
United States | 3 | 1% |
India | 1 | <1% |
Japan | 1 | <1% |
Uruguay | 1 | <1% |
Unknown | 271 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 65 | 23% |
Researcher | 40 | 14% |
Student > Master | 25 | 9% |
Student > Bachelor | 24 | 9% |
Student > Postgraduate | 20 | 7% |
Other | 48 | 17% |
Unknown | 58 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 66 | 24% |
Agricultural and Biological Sciences | 44 | 16% |
Biochemistry, Genetics and Molecular Biology | 25 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 18 | 6% |
Immunology and Microbiology | 17 | 6% |
Other | 38 | 14% |
Unknown | 72 | 26% |